CIK: 1577071 - Address: Biogen Inc., 225 Binney Street, Cambridge, MA 02142
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1112843120-119
S%wins0000010017

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/5/16 17:06
4/2/16
BIIBBiogen Inc.DEHealthBioPrdBiological Products, (No DiagArtavanis-Tsakonas SpyridonMAOEVP,ChieM.d00.00331453D-15-36-8-14-1234503-8183
2/25/16 17:07
2/23/16
BIIBBiogen Inc.DEHealthBioPrdBiological Products, (No DiagArtavanis-Tsakonas SpyridonMAOSVP,ChieM.d00.0033063D-26-36-8-11-8-54-214-34229
2/17/16 17:54
2/12/16
BIIBBiogen Inc.DEHealthBioPrdBiological Products, (No DiagArtavanis-Tsakonas SpyridonMAOSVP,ChieM.d00.00331762D-22-35-18-12-13-1-62-2-3-60198
4/3/15 16:24
4/2/15
BIIBBiogen Inc.DEHealthBioPrdBiological Products, (No DiagArtavanis-Tsakonas SpyridonMAOSVP,ChieM.d00.003311392D11133272210-9-413-7-2-31-36
2/17/15 20:50
2/12/15
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagArtavanis-Tsakonas SpyridonMAOSVP,ChieM.d00.003311D1361916221580-1137-2-22-36
12/16/14 16:36
12/15/14
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagArtavanis-Tsakonas SpyridonMAOSVP,ChieS-686346.5033-2-850D1222210359-2-22843120-11
4/3/14 16:27
4/2/14
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagArtavanis-Tsakonas SpyridonMAOSVP,ChieM.d00.00331772D145582611-8-7-15-40-69736
2/14/14 16:45
2/12/14
BIIBBiogen Idec Inc.DEHealthBioPrdBiological Products, (No DiagArtavanis-Tsakonas SpyridonMAOSVP,ChieM.d00.00331722D17898553917873265-12319

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact